New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
05:34 EDTBAYRY, REGNBayer, Regeneron announce regulatory submission of Eylea in Japan
Regeneron Pharmaceuticals (REGN) announced that Bayer HealthCare's (BAYRY) Japanese subsidiary, Bayer Yakuhin, has submitted an application for marketing authorization for Eylea Injection for the treatment of patients with diabetic macular edema, or DME, to the Japanese Ministry of Health, Labour and Welfare.
News For BAYRY;REGN From The Last 14 Days
Check below for free stories on BAYRY;REGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
07:57 EDTREGNCambridge Healthtech Institute to hold a summit
6th Annual Bioprocessing Summit to be held in Boston on August 18-22.
August 11, 2014
07:07 EDTREGNRegeneron reports Q2 EPS 9c, consensus 6c
Subscribe for More Information
05:32 EDTBAYRY, REGNRegeneron Eylea injection receives EU approval for DME treatment
Subscribe for More Information
August 7, 2014
17:12 EDTREGNRegeneron reports 8.1% passive stake in Avalanche Biotechnologies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use